Internal Medicine, Cardiovascular Disease · Lake Success, NY
NPI
1831134865
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1983 Marcus Ave, Suite E 124
Lake Success, NY, 11042
Phone (516) 627-2121
Groups this clinician bills Medicare through
Medicare paid, 2024
$528K
4,918 services
Medicare patients, 2024
468
Average age 77
Drug cost, 2024
$2.9M
11,321 prescriptions
Company payments, 2025
$41K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald D D'Agostino was code 99214 (office e&m - established), 1,281 times for 341 patients. In total Ronald D D'Agostino billed 4,918 services in 40 codes, and Medicare paid $528K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,281 | 341 | $104.25 | $134K |
| 93000 Electrocardiogram | Office | 631 | 328 | $12.40 | $7,824 |
| 93298 External Electrocardiographic Monitoring | Office | 251 | 33 | $84.58 | $21K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 229 | 227 | $165.25 | $38K |
| 93306 Echocardiography (TTE/TEE) | Office | 212 | 203 | $170.18 | $36K |
| 93978 Duplex Scan - Extremity Arteries | Office | 210 | 205 | $159.39 | $33K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 210 | 105 | $77.15 | $16K |
| 93975 Duplex Scan - Extremity Arteries | Office | 170 | 169 | $239.74 | $41K |
| 93925 Duplex Scan - Extremity Arteries | Office | 163 | 162 | $216.09 | $35K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 152 | 38 | $4.68 | $711 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 131 | 104 | $13.77 | $1,804 |
| 99213 Office E&M - Established | Office | 123 | 83 | $71.51 | $8,796 |
| 93015 Electrocardiogram | Office | 114 | 110 | $64.67 | $7,372 |
| 78452 Myocardial Perfusion Scan | Office | 105 | 105 | $390.76 | $41K |
| 95800 Sleep Study | Office | 85 | 82 | $123.11 | $10K |
By year: 2022 $591K for 5,160 services; 2023 $539K for 5,090 services; 2024 $528K for 4,918 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 56 | 47 | $8.65 | $484 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald D D'Agostino prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,576 prescriptions and refills. In total Ronald D D'Agostino wrote 11,321 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,576 | 4,375 | 435 | $25K |
| Carvedilol Generic | 1,096 | 2,908 | 291 | $10K |
| Jardiance Empagliflozin | 678 | 1,450 | 178 | $836K |
| Ramipril Generic | 597 | 1,638 | 183 | $6,903 |
| Valsartan Generic | 525 | 1,249 | 160 | $14K |
| Eplerenone Generic | 449 | 1,030 | 131 | $30K |
| Xarelto Rivaroxaban | 440 | 914 | 110 | $494K |
| Ezetimibe Generic | 379 | 1,058 | 108 | $11K |
| Furosemide Generic | 266 | 628 | 83 | $1,387 |
| Pantoprazole Sodium Generic | 239 | 633 | 74 | $3,072 |
| Vascepa Icosapent Ethyl | 217 | 428 | 60 | $143K |
| Levothyroxine Sodium Generic | 207 | 584 | 62 | $4,019 |
| Amlodipine Besylate Generic | 187 | 500 | 64 | $1,259 |
| Mounjaro Tirzepatide | 185 | 221 | 35 | $230K |
| Metformin Hcl Generic | 175 | 467 | 52 | $1,149 |
Brand drugs: 2,746 claims; generic drugs: 8,557 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald D D'Agostino $41K ($41K in general payments such as food, travel and fees) from 22 companies. The largest payer was Boston Scientific Corporation with $15K.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 24 | $15K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $9,705 |
| Amgen Inc. AMGN | 24 | $9,214 |
| Lilly USA, LLC LLY | 5 | $2,639 |
| AtriCure, Inc. ATRC | 6 | $958 |
| Abbott Laboratories ABT | 5 | $402 |
| Heartflow, Inc. HTFL | 3 | $287 |
| CVRx, Inc. CVRX | 5 | $259 |
| Medtronic, Inc. MDT | 3 | $257 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $254 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.